Trials / Completed
CompletedNCT00816803
Cell Transplant in Spinal Cord Injury Patients
Autologous Bone Marrow Derived Cell Transplant in Spinal Cord Injury Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 10 Years – 36 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to assess the safety of autologous bone marrow derived cell transplant in chronic spinal cord injury patients. The hypothesis is that the availability of bone marrow derived mesenchymal stem cells at the sites of injury promote neuronal regeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous bone marrow transplant | |
| PROCEDURE | Physical therapy |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2009-01-05
- Last updated
- 2009-01-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT00816803. Inclusion in this directory is not an endorsement.